| 发明名称 |
3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists |
| 摘要 |
Disclosed are compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
|
| 申请公布号 |
US2004034229(A1) |
申请公布日期 |
2004.02.19 |
| 申请号 |
US20020269775 |
申请日期 |
2002.10.11 |
| 申请人 |
SCHERING CORPORATION |
发明人 |
TAVERAS ARTHUR G.;DWYER MICHAEL;FERREIRA JOHAN A.;GIRIJAVALLABHAN VIYYOOR M.;CHAO JIANPING;BALDWIN JOHN J.;MERRITT J. ROBERT;LI GE |
| 分类号 |
A61K31/337;A61K31/4015;A61K31/402;A61K31/4025;A61K31/4155;A61K31/4192;A61K31/4439;A61K31/454;A61K31/496;A61K31/506;A61K31/5377;A61K31/56;A61K38/00;A61K38/21;A61K38/22;A61K38/55;A61K39/395;A61K45/00;A61P1/02;A61P1/04;A61P1/16;A61P1/18;A61P3/10;A61P7/02;A61P9/00;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P11/08;A61P11/10;A61P13/12;A61P17/02;A61P17/06;A61P19/02;A61P19/06;A61P19/10;A61P21/00;A61P25/00;A61P25/28;A61P27/02;A61P31/04;A61P31/18;A61P31/20;A61P31/22;A61P35/00;A61P37/06;A61P37/08;A61P43/00;C07D207/44;C07D207/456;C07D401/12;C07D403/12;C07D405/12;C07D409/12;C07D409/14;C07D417/12;(IPC1-7):C07D417/14;C07D413/14;C0743/14;C0749/14;C0745/14 |
主分类号 |
A61K31/337 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
